Tracey Worthington Stice
Geschäftsführer bei Aruna Bio, Inc.
Profil
Tracey Worthington Stice is currently the Chief Operating Officer at Aruna Bio, Inc. They previously worked as a Principal at BresaGen, Inc. and Astellas Institute for Regenerative Medicine.
Ms. Stice completed their undergraduate degree at the University of Massachusetts.
Aktive Positionen von Tracey Worthington Stice
| Unternehmen | Position | Beginn |
|---|---|---|
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Geschäftsführer | 01.06.2005 |
Ehemalige bekannte Positionen von Tracey Worthington Stice
| Unternehmen | Position | Ende |
|---|---|---|
| BresaGen, Inc. | Corporate Officer/Principal | - |
| OCATA THERAPEUTICS INC | Corporate Officer/Principal | - |
Ausbildung von Tracey Worthington Stice
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
| BresaGen, Inc. | Commercial Services |
